PF-Atlas › Clinical Trials › NCT05621252

Imaging Evaluation of PLN-74809 in Participants With IPF

PLN-74809 · Phase 2

Registry ID
NCT05621252
Phase
Phase 2
Status
Completed
Drug / intervention
PLN-74809
Sponsor
Pliant Therapeutics, Inc.
Start
2022-07-13

About this trial

PLN-74809 is evaluated in NCT05621252, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Pliant Therapeutics, Inc.. Current status: Completed.

View NCT05621252 on ClinicalTrials.gov →

Explore related

PLN-74809 — Treatment profileAll PLN-74809 trialsAll IPF trials

Related trials

PLN-74809 — INTEGRIS-IPFPLN-74809 — NCT04072315PLN-74809 — NCT04396756PLN-74809 — NCT06097260
Medical disclaimer. This page summarizes public trial data for NCT05621252 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.